Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

Published:2021-08-27 Issue:34 Volume:70 Page:1163-1166
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Nanduri Srinivas,Pilishvili Tamara,Derado Gordana,Soe Minn Minn,Dollard Philip,Wu Hsiu,Li Qunna,Bagchi Suparna,Dubendris Heather,Link-Gelles Ruth,Jernigan John A.,Budnitz Daniel,Bell Jeneita,Benin Andrea,Shang Nong,Edwards Jonathan R.,Verani Jennifer R.,Schrag Stephanie J.

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health(social science),Epidemiology

Reference8 articles.

1. The Advisory Committee on Immunization Practices’ updated interim recommendation for allocation of COVID-19 vaccine—United States, December 2020.;Dooling;MMWR Morb Mortal Wkly Rep,2021

2. First-dose COVID-19 vaccination coverage among skilled nursing facility residents and staff.;Gharpure;JAMA,2021

3. Direct and indirect effectiveness of mRNA vaccination against SARS-CoV-2 infection in long-term care facilities in Spain.;Monge;Emerg Infect Dis,2021

4. Working Group for the surveillance and control of COVID-19 in Spain. Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021.;Mazagatos;Euro Surveill,2021

5. Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks—Connecticut, December 2020–February 2021.;Britton;MMWR Morb Mortal Wkly Rep,2021

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination;Vaccines;2024-08-22

2. Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac;Vaccines;2024-08-15

3. Vaccination status and disease severity of COVID-19 in different phases of the pandemic;Human Vaccines & Immunotherapeutics;2024-06-04

4. Evaluating length of immune response to SARS-CoV2 vaccine: A cohort review of spike protein antibody titer after vaccination;Clinical Immunology Communications;2024-06

5. Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers;GeroScience;2024-05-25